Porphyromonas gingivalis Cell Wall Components Induce Programmed Death Ligand 1 (PD-L1) Expression on Human Oral Carcinoma Cells by a Receptor-Interacting Protein Kinase 2 (RIP2)-Dependent Mechanism

被引:28
|
作者
Groeger, S. [1 ]
Denter, F. [1 ]
Lochnit, G. [2 ,3 ,4 ]
Schmitz, M. L. [2 ,3 ,4 ]
Meyle, J. [1 ]
机构
[1] Justus Liebig Univ Giessen, Dept Periodontol, Giessen, Germany
[2] Inst Biochem, Giessen, Germany
[3] German Ctr Lung Res, Giessen, Germany
[4] Justus Liebig Univ, Giessen, Germany
关键词
PD-L1; B7-H1; Porphyromonas gingivalis; immune evasion; immune suppression; signaling pathway; GASTRIC EPITHELIAL-CELLS; OUTER-MEMBRANE; B7-DC RECEPTORS; T-CELLS; B7-H1; NOD1; INNATE; PEPTIDOGLYCAN; SURAMIN; FAMILY;
D O I
10.1128/IAI.00051-20
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Programmed death-ligand 1 (PD-L1/B7-H1) serves as a cosignaling molecule in cell-mediated immune responses and contributes to chronicity of inflammation and the escape of tumor cells from immunosurveillance. Here, we investigated the molecular mechanisms leading to PD-L1 upregulation in human oral carcinoma cells and in primary human gingival keratinocytes in response to infection with Porphyromonas gingivalis (P. gingivalis), a keystone pathogen for the development of periodontitis. The bacterial cell wall component peptidoglycan uses bacterial outer membrane vesicles to be taken up by cells. Internalized peptidoglycan triggers cytosolic receptors to induce PD-L1 expression in a myeloid differentiation primary response 88 (Myd88)-independent and receptor-interacting serine/threonine-protein kinase 2 (RIP2)-dependent fashion. Interference with the kinase activity of RIP2 or mitogen-activated protein (MAP) kinases interferes with inducible PD-L1 expression.
引用
收藏
页数:13
相关论文
共 45 条
  • [1] miRNA-A and programmed death ligand 1 (PD-L1) expression in oral squamous cell carcinoma
    Hyung, Hong
    Ko, Yoon Ho
    Jin, Lee Hee
    Jeon, Sang Hoon
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [2] Expression of Programmed Death-Ligand 1 and 2 (PD-L1/2) on Tumor cells of Oropharyngeal Squamous Cell Carcinoma (OPSCC)
    Wuerdemann, N.
    Gueltekin, S. E.
    Wittekindt, C.
    Sharma, S. J.
    Schubotz, A. B.
    Gattenloehner, S.
    Tharun, L.
    Baris, E.
    Sengueven, B.
    Yildirim, B.
    Buettner, R.
    Speel, E. -J.
    Wagner, S.
    Klussmann, J. -P.
    Quaas, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 95 - 95
  • [3] Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma
    Hanna, Glenn J.
    Kacew, Alec J.
    Tanguturi, Anusha R.
    Grote, Hans J.
    Vergara, Victoria
    Brunkhorst, Beatrice
    Rabinowits, Guilherme
    Thakuria, Manisha
    LeBoeuf, Nicole R.
    Ihling, Christian
    DeCaprio, James A.
    Lorch, Jochen H.
    FRONTIERS IN MEDICINE, 2020, 7
  • [4] Programmed Cell Death-Ligand 1 (PD-L1) Expression in Oral Cavity Squamous Cell Carcinoma (OSCC)
    Satgunaseelan, Laveniya
    Madore, Jason
    Chia, Noel
    Lum, Trina
    Palme, Carsten E.
    Boyer, Michael
    Scolyer, Richard A.
    Clark, Jonathan R.
    Gupta, Ruta
    MODERN PATHOLOGY, 2016, 29 : 329A - 329A
  • [5] Programmed Cell Death-Ligand 1 (PD-L1) Expression in Oral Cavity Squamous Cell Carcinoma (OSCC)
    Satgunaseelan, Laveniya
    Madore, Jason
    Chia, Noel
    Lum, Trina
    Palme, Carsten E.
    Boyer, Michael
    Scolyer, Richard A.
    Clark, Jonathan R.
    Gupta, Ruta
    LABORATORY INVESTIGATION, 2016, 96 : 329A - 329A
  • [6] Differential expression of programmed cell death ligand 1 (PD-L1) and inflammatory cells in basal cell carcinoma subtypes
    Matias Gompertz-Mattar
    Juan Perales
    Aditi Sahu
    Sebastián Mondaca
    Sergio Gonzalez
    Pablo Uribe
    Cristian Navarrete-Dechent
    Archives of Dermatological Research, 2022, 314 : 777 - 786
  • [7] Differential expression of programmed cell death ligand 1 (PD-L1) and inflammatory cells in basal cell carcinoma subtypes
    Gompertz-Mattar, Matias
    Perales, Juan
    Sahu, Aditi
    Mondaca, Sebastian
    Gonzalez, Sergio
    Uribe, Pablo
    Navarrete-Dechent, Cristian
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2022, 314 (08) : 777 - 786
  • [8] Clinicopathological characteristics of squamous cell carcinoma of the lung with programmed cell death ligand 1 (PD-L1) protein expression.
    Huynh, Tiffany
    Chi, Anthony
    Oyarvide, Vicente Morales
    Gainor, Justin F.
    Hata, Aaron N.
    Lanuti, Michael
    Mark, Eugene J.
    Engelman, Jeffrey A.
    Mino-Kenudson, Mari
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Immunohistochemical expression of programmed death ligand-1 (PD-L1) in oral squamous cell carcinoma and its clinicopathological correlation
    Kumar, M.
    Babu, S.
    Ratnakar, S.
    VIRCHOWS ARCHIV, 2020, 477 : S78 - S79
  • [10] Prognostic Impact of Adenosine Receptor 2 (A2aR) and Programmed Cell Death Ligand 1 (PD-L1) Expression in Colorectal Cancer
    Wu, Zhaoying
    Yang, Lin
    Shi, Linsen
    Song, Hu
    Shi, Peicong
    Yang, Ting
    Fan, Ruizhi
    Jiang, Tao
    Song, Jun
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019